News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Rituximab with chemotherapy effective against advanced childhood Burkitt's lymphoma
By Gene Emery (Reuters Health) - Six doses of rituximab can help children with high-grade, high-risk mature B-cell non-Hodgkin's lymphoma live longer, but at a risk of infections and
Jury out on benefits, harms of ventilation strategies for COVID-19
By Marilynn Larkin NEW YORK (Reuters Health) - Evidence is lacking on the effectiveness of noninvasive ventilation (NIV) and invasive mechanical ventilation (IMV) for COVID-19 patients, and the safety
Migraines during pregnancy associated with increased maternal stroke risk
By Lisa Rappaport (Reuters Health) - Women who experience migraines during pregnancy are more likely to have a stroke during pregnancy, delivery, or the postpartum period, a new study suggests.
IntelliCare mobile apps associated with improved anxiety, depression
By Lisa Rappaport (Reuters Health) - IntelliCare, a coach-supported suite of apps designed to improve mental health, may help ease depression and anxiety symptoms in primary care patients, a small
COVID SCIENCE-Convalescent plasma not helpful in China study; timing of test may affect result
By Nancy Lapid June 3 (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the
Even with 10-day wait, suicide by gun 100 times higher within month of purchase
By Gene Emery (Reuters Health) - The risk of suicide by firearm jumps 100-fold during the first month after purchasing a handgun, even if the buyer is subject to a 10-day waiting period, according to
Malaria drug touted by Trump ineffective to prevent COVID-19 in high profile study
By Michael Erman (Reuters) - The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was shown to be ineffective in preventing infection in people exposed to the
'Global epicenter' of problematic cholesterol has shifted
By Linda Carroll (Reuters Health) - High cholesterol is on the rise in low- and middle-income countries while declining in wealthier ones, an international team of researchers finds in a new analysis.
Vaccine group plans advance market agreement for COVID-19 vaccines
By Kate Kelland LONDON (Reuters) - The GAVI vaccines alliance is to launch an Advance Market Commitment (AMC) for future COVID-19 vaccines which it says will help secure access to the new shots for
Dutch coronavirus study: children are not big spreaders
By Reuters Staff AMSTERDAM (Reuters) - A study by the Netherlands' National Institute for Health (RIVM) published on Wednesday concluded that children under the age of 12 play little role in
WHO set to resume hydroxychloroquine trial in battle against COVID-19
By Michael Shields and Emma Farge GENEVA (Reuters) - The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday,
Brazil to start testing Oxford vaccine against the coronavirus this month
By Eduardo Simões SAO PAULO (Reuters) - Brazil this month will start testing an experimental vaccine against the novel coronavirus being developed by researchers at the University of Oxford and
Vietnam says most serious COVID-19 patient on path to recovery
By Reuters Staff HANOI (Reuters) - Vietnam's most gravely-ill COVID-19 patient, a British pilot who works for its national airline, has started to recover from the illness and may no longer require a
Coagulation abnormalities complicate mechanical thrombectomy in stroke patients with COVID-19
By Will Boggs MD NEW YORK (Reuters Health) - Coagulation abnormalities can interfere with mechanical thrombectomy and successful revascularization in stroke patients with COVID-19, according to a new
High plasma viscosity seen in critically ill COVID-19 patients
By Anne Harding NEW YORK (Reuters Health) - Abnormally high plasma viscosity could be contributing to the thrombotic complications seen in many COVID-19 patients, a new report suggests. Dr. Cheryl L.
Doctors can help parents cope in the NICU
By Carolyn Crist NEW YORK (Reuters Health) - Parenting a newborn can be a tough journey, and bonding with a new baby in a neonatal intensive-care unit (NICU) is even more difficult given the medical
Adjuvant osimertinib boosts disease-free survival in early non-small-cell lung cancer
By Megan Brooks NEW YORK (Reuters Health) - Treatment with osimertinib after surgery for localized, non-small-cell lung cancer (NSCLC) harboring EGFR mutations significantly improved disease-free
'Encouraging' results in trial of FOLFIRINOX for advanced gastroesophageal cancer
By Anne Harding NEW YORK (Reuters Health) - A four-drug combination is associated with improved overall and progression-free survival (PFS) in patients with advanced gastroesophageal adenocarcinoma, a
Kids with ADHD often on multiple medications
By Megan Brooks NEW YORK (Reuters Health) - Rates of psychotropic polypharmacy in children with attention-deficit/hyperactivity disorder (ADHD) continue to rise in the U.S., according to a national
COVID-19 exacts high toll in patients with diabetes
By Megan Brooks NEW YORK (Reuters Health) - About one in 10 patients with diabetes dies within seven days of being hospitalized with COVID-19 and one in five requires intubation for mechanical
COVID-19 more common with ApoE e4 genotype
By Will Boggs MD NEW YORK (Reuters Health) - Homozygosity for the ApoE e4 genotype appears to be associated with a higher rate of COVID-19, according to new findings. "We presented data on UK Biobank
Mortality spiked 155% in Spain in worst week of epidemic
By Emma Pinedo MADRID (Reuters) - New official data in Spain showed on Wednesday that many more people have died than usual this year than the recorded number of coronavirus fatalities and revealed a
Coronavirus is not high threat to workers, EU says, causing outcry
By Francesco Guarascio BRUSSELS (Reuters) - The European Commission classified the new coronavirus as a mid-level threat to workers, drawing criticism from socialist lawmakers because the move will
COVID-19 death toll among nurses doubled in past month, says nurses group
By Cecile Mantovani GENEVA (Reuters) - More than 600 nurses worldwide are known to have died from COVID-19, which has infected an estimated 450,000 healthcare workers, the International Council of
UK doctors to trial ibuprofen in COVID-19 patients with breathing difficulties
By Reuters Staff LONDON (Reuters) - British doctors are trialling a formulation of anti-inflammatory ibuprofen to see if it reduces respiratory failure in patients with severe symptoms of COVID-19.
UPDATE 1-Study panning anti-malaria drug Trump took against COVID faces new questions
(Adds details, NEJM concern, changes headline of story originally published June 2) By Michael Erman NEW YORK (Reuters) - British medical journal The Lancet on Tuesday said it had concerns (
Risks of surgery may be higher when coronavirus is circulating
By Linda Carroll (Reuters Health) - In a review of data on more than 1,000 postoperative patients with COVID-19, an international team of researchers found that half experienced complications, such as
Reasonable to expect some coronavirus vaccine by year-end -Pentagon researcher
By David Brunnstrom, Carl O'Donnell and Julie Steenhuysen WASHINGTON (Reuters) - A senior U.S. Army vaccine researcher said on Tuesday it was reasonable to expect that some sort of coronavirus vaccine
Medical journal concerned about validity of influential hydroxychloroquine study
By Michael Erman NEW YORK (Reuters) - British medical journal The Lancet on Tuesday said it had concerns (https://bit.ly/300q8Bp) about data behind an influential article that found hydroxychloroquine
Racial disparities in receipt of opioid use disorder drugs among U.S. pregnant women
By Lisa Rapaport (Reuters Health) - Pregnant women with opioid use disorder are more likely to receive medications such as methadone or buprenorphine when they're white than when they're Hispanic or
Loss of smell, taste with COVID-19 more prevalent than previously thought
By Marilynn Larkin NEW YORK (Reuters Health) - The prevalence of self-reported smell and taste dysfunction in COVID-19 is higher than previously thought and may present in different ways, researchers
Peer leadership, sports-team logos help homeless youth mask up
By Anne Harding NEW YORK (Reuters Health) - Young people who are respected by their peers can motivate those peers to adopt healthy behaviors, a new report on mask-wearing among youth living in
Tucatinib a 'game changer' in HER+ breast cancer with brain metastases
By Megan Brooks NEW YORK (Reuters Health) - In patients with HER2+ metastatic breast cancer (MBC) with brain lesions, adding tucatinib to trastuzumab and capecitabine significantly delays progression
COVID-19 illness appears less severe in children, review confirms
By Will Boggs MD NEW YORK (Reuters Health) - More evidence that children with COVID-19 appear to have less severe disease than adults comes from a new review. "There are several obstacles to the
Appendicitis admissions declining during COVID-19 pandemic
By Reuters Staff NEW YORK (Reuters Health) - The number of admissions for acute appendicitis has declined significantly since the beginning of the COVID-19 pandemic, researchers in Israel report.
Compression stockings may not help prevent clots after elective surgery
By Lisa Rapaport (Reuters Health) - Adding compression stockings to heparin doesn't work any better than heparin alone for preventing venous thromboembolism (VTE) after elective surgery, a
INTERVIEW-AIDS took away our freedom. The pandemic is doing the same, says Patti Smith
By Rachel Savage LONDON (Thomson Reuters Foundation) - Since punk rock pioneer Patti Smith agreed to write the introduction to a new version of "De Profundis," the anguished letter Oscar Wilde wrote
SPECIAL REPORT-U.S. school closures dramatically shrinking public education, Reuters finds
By M.B. Pell, Kristina Cooke and Benjamin Lesser NEW YORK (Reuters) - Jennifer Panditaratne's third-grade daughter had been seeing a reading specialist once a week before her Florida school closed
Indian girl's suicide sparks protest over access to online classes
By Jose Devasia KOCHI (Thomson Reuters Foundation) - Students protested in southern India on Tuesday after the suicide of a teenage girl who was unable to attend online classes because she did not
EU eyes overhaul of pharma rules to tackle vaccine, antibiotic shortages
BRUSSELS, June 2 (Reuters) - The European Commission on Tuesday started a process that could lead to reforms of drug manufacturing to limit shortages of vaccines and antibiotics and make medicines
Dehydration pathway for pediatric gastroenteritis may cut resource use, costs
By Reuters Staff NEW YORK (Reuters Health) - Implementation of an evidence-based algorithm for managing pediatric gastroenteritis was followed by a significant reduction in IV-fluid administration and
Longer rituximab therapy boosts remission in ANCA-associated vasculitis
By Will Boggs MD NEW YORK (Reuters Health) - Long-term rituximab use lowers the chance of relapse of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), compared with standard
Evolocumab curbs risks in patients with recent MIs
By David Douglas NEW YORK (Reuters Health) - Treatment with the PCSK9 inhibitor evolocumab (Repatha, Amgen) in patients who have experienced an myocardial infarct (MI) within 12 months reduces risk
UPDATE 1-Japan allows saliva-based tests to boost coronavirus detection
(Updates with alert from Tokyo government) By Kiyoshi Takenaka TOKYO (Reuters) - Japan's government said on Tuesday it has approved saliva-based tests for the new coronavirus, offering a safer,
UPDATE 1-New virus cluster spurs Hong Kong to extend border curbs and limit on gatherings
By Donny Kwok HONG KONG (Reuters) - Voicing worries over a new cluster of coronavirus cases, Hong Kong decided on Tuesday to keep its borders almost completely closed to foreigners until mid-September
Frequent testing, less contact recommended to get Hollywood cameras rolling again
By Reuters Staff LOS ANGELES (Reuters) - Hollywood studios and labor unions on Monday proposed extensive coronavirus testing and other safeguards to allow actors and crew members to resume movie and
Japan allows saliva-based tests to boost coronavirus detection
By Kiyoshi Takenaka TOKYO (Reuters) - Japan's government said on Tuesday it has approved saliva-based tests for the new coronavirus, offering a safer, simpler way to diagnose infection than nasal
No new COVID sufferers, 300 asymptomatic, after Wuhan-wide tests
By Reuters Staff BEIJING (Reuters) - The Chinese city of Wuhan, where the novel coronavirus outbreak began, has found no new cases of people suffering from COVID-19 after testing almost its entire
'Often mistrusted': UK stats watchdog criticises COVID-19 test data
By Andy Bruce LONDON (Reuters) - Britain's statistics watchdog chided the government on Tuesday for publishing data on coronavirus tests that it said were "far from complete and comprehensible". "The
Black and Asian people in England more likely to die from COVID-19, says public health report
By Reuters Staff LONDON (Reuters) - Black and Asian people in England are up to 50% more likely to die after being infected with COVID-19, an official study said on Tuesday, reinforcing previous
UK records almost 62,000 excess deaths during pandemic: ONS official
By Reuters Staff LONDON (Reuters) - Some 62,000 more people than usual have died in the United Kingdom during this year's coronavirus pandemic according to the latest available data, an expert from
S.Korea expects human trials of Celltrion's potential COVID-19 treatment in Europe
By Reuters Staff SEOUL (Reuters) - South Korea expects clinical trials of Celltrion Inc's experimental COVID-19 monoclonal antibody to begin in Europe next month and aims to secure sizable supplies of
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
By Deena Beasley (Reuters) - Gilead Sciences Inc is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones
Proteins in COVID-19 patients' blood could predict severity of illness, study finds
By Kate Kelland LONDON (Reuters) - Scientists have found 27 key proteins in the blood of people infected with COVID-19 which they say could act as predictive biomarkers for how ill a patient could
Privately insured diabetes patients 'relatively shielded' from insulin price increases
By Megan Brooks NEW YORK (Reuters Health) - A new study discounts the notion that insulin cost-sharing is excessive for privately insured patients. Despite the rising price of insulin paid by
Global Covid-19 pandemic could lead to 28 million surgeries canceled worldwide
By Lisa Rapaport (Reuters Health) - An estimated 28.4 million elective surgeries worldwide will be cancelled during the 12 weeks of peak disruption due to the global Covid-19 pandemic, according to a
U.S. court refuses to shield VW in diesel scandal lawsuits
By David Shepardson and Jonathan Stempel (Reuters) - A U.S. appeals court ruled on Monday that Volkswagen AG cannot escape potential financial penalties from two counties in Florida and Utah that may
U.S. EPA moves to curb state powers to deny permits for energy projects
By Valerie Volcovici WASHINGTON (Reuters) - U.S. Environmental Protection Agency chief Andrew Wheeler signed on Monday a rule limiting state powers to block energy infrastructure projects, setting up
Hidradenitis suppurativa tied to increased cancer risk
By Marilynn Larkin NEW YORK (Reuters Health) - Hidradenitis suppurativa (HS) was associated with an increased risk of cancer in a population-based study in Korea. Dr. Mi Woo Lee of the University of
SARS-CoV-2 can enter brain through olfactory tract
By Will Boggs MD NEW YORK (Reuters Health) - MRI brain changes in a patient with COVID-19 and anosmia are consistent with SARS-CoV-2 invasion by way of the olfactory tract, researchers report. "Based
Paper towel soaked in salt water may improve masks' ability to block viruses, bacteria
By Linda Carroll (Reuters Health) - When paper towels are soaked in a saline solution and then allowed to dry, they can effectively filter out particles comparable in size to the SARS-CoV-19 virus, a
Patient-related factors key to COVID-19 disease severity
By Marilynn Larkin NEW YORK (Reuters Health) - Patient-related factors, including age, lymphocytopenia and cytokine levels are associated with COVID-19 disease severity, according to researchers in
UPDATE 1-Wildlife groups up pressure on Big Pharma to curb crab blood addiction
(Adds Eli Lilly comments) By John Miller ZURICH (Reuters) - Wildlife advocates are pushing drugmakers to curb the use of horseshoe crab blood by switching to a synthetic alternative for safety tests,
American Indians, Alaska natives less likely to get optimal therapy for atrial fibrillation
By Marilynn Larkin NEW YORK (Reuters Health) - American Indians and Alaska natives (AI/ANs) with atrial fibrillation (AF) are less likely to be treated with oral anticoagulants (OACs) and rhythm
Italy launches COVID-19 contact-tracing app amid privacy concerns
By Reuters Staff ROME (Reuters) - Italy on Monday released a contested mobile app to trace coronavirus infections in four regions before extending it to the whole country, despite widespread
U.S. health experts, officials warn protests may add to virus spread
By Caroline Humer NEW YORK (Reuters) - Public health experts and government officials, including New York's governor, are warning that large street protests over racial inequities and excessive police
WHO pushes to keep ties with 'generous' U.S. despite Trump's exit move
By Kate Kelland and Josephine Mason LONDON (Reuters) - The head of the World Health Organization (WHO) on Monday praised the United States' "immense" and "generous" contribution to global health in a
WHO and other experts say no evidence of COVID-19 losing potency
By Kate Kelland and Emilio Parodi LONDON/MILAN (Reuters) - World Health Organization experts and a range of other scientists said on Monday there was no evidence to support an assertion by a high
COVID SCIENCE-In-home antibody test shows promise; recovering surgery patients at risk from coronavirus
By Nancy Lapid (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness
UPDATE 1-INSIGHT-Scientists hunt pandemic hotspots in race to test vaccines
(Adds Brazil health ministry comment, paragraph 24) By Kate Kelland and Julie Steenhuysen LONDON/CHICAGO (Reuters) - The first wave of the COVID-19 pandemic may be waning. For vaccine developers, that
UPDATE 1-Congo hit by a second, simultaneous Ebola outbreak
(Adds background, detail) By Reuters Staff KINSHASA (Reuters) - Authorities in Congo announced a new Ebola outbreak in the western city of Mbandaka on Monday, adding to another epidemic of the virus
'Electrogenetic' insulin release restores normoglycemia in diabetes mouse model
By Linda Carroll (Reuters Health) - Human cells genetically engineered to respond to electrical stimulation could produce and release insulin on demand when triggered with a remote control device,
UPDATE 2-Gilead says remdesivir helped moderate COVID-19 patients improve
(Adds details of results, physician comments) By Reuters Staff (Reuters) - Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate
Sign here first: U.S. salons, gyms, offices require coronavirus waivers
By Suzanne Barlyn and John McCrank (Reuters) - As U.S. businesses reopen after weeks of pandemic lockdowns, many have been posting coronavirus disclaimers or requiring employees and patrons to sign
Armed with disinfectant and admonishments, S.Korean robot fights coronavirus spread
By Hyonhee Shin SEOUL (Reuters) - A self-driving robot equipped with cameras and an LED screen greets visitors at the lobby in the headquarters of South Korea's largest mobile operator, checking their
Rwandan medical workers deploy robots to minimize coronavirus risk
By Clement Uwiringiyimana KIGALI (Reuters) - At the Kanyinya COVID-19 treatment facility a short distance from Rwanda's capital Kigali, Akazuba, Ikizere and Ngabo report for duty, but these are no
FEATURE-Workers living in Mexico helping California's pandemic health response
By Laura Gottesdiener EL CENTRO, Calif. (Reuters) - Hundreds of Mexicans and Americans who live south of the border enter southern California's hospitals every day. But these are not the patients -
EXCLUSIVE-Russia to roll out its first approved COVID-19 drug next week
By Andrew Osborn MOSCOW (Reuters) - Russia will start giving its first drug approved to treat COVID-19 to patients next week, its state financial backer told Reuters, a move it hopes will ease strains
UPDATE 1-Gilead says remdesivir helped moderate COVID-19 patients improve
(Adds details of mixed results, background, analyst quote) By Reuters Staff (Reuters) - Gilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate
Thailand races to create COVID vaccine, eyes possible medical tourism boost
By Juarawee Kittisilpa AYUTTHAYA, Thailand (Reuters) - Momentum is building behind Thailand's push to create its own coronavirus vaccine, with more manpower and resources dedicated to the effort amid
Wildlife groups up pressure on Big Pharma to curb crab blood addiction
By John Miller ZURICH (Reuters) - Wildlife advocates are pushing drugmakers to curb their use of horseshoe crab blood by switching to a synthetic alternative for safety tests, including those needed
New coronavirus losing potency, top Italian doctor says
By Reuters Staff ROME (Reuters) - The new coronavirus is losing its potency and has become much less lethal, a senior Italian doctor said on Sunday. "In reality, the virus clinically no longer exists
Congo declares new Ebola epidemic, 1,000 km from eastern outbreak
By Reuters Staff KINSHASA (Reuters)Democratic Republic of Congo declared a new Ebola epidemic on Monday in the western city of Mbandaka, more than 1,000 km (620 miles) away from an ongoing outbreak of
EU urges U.S. to reconsider decision to cut ties with WHO
By Kate Abnett and Arno Schuetze BRUSSELS (Reuters) - The European Union urged the United States on Saturday to reconsider its decision to cut ties with the World Health Organization over its handling
Eli Lilly starts human study of potential COVID-19 antibody treatment
By Reuters Staff (Reuters) - Eli Lilly and Co said on Monday it had started an early-stage trial to test its potential treatment for COVID-19, in the world's first study of an antibody treatment
INSIGHT-Scientists hunt pandemic hotspots in race to test vaccines
By Kate Kelland and Julie Steenhuysen LONDON/CHICAGO (Reuters) - The first wave of the COVID-19 pandemic may be waning. For vaccine developers, that could be a problem. Scientists in Europe and the
Gilead says remdesivir helped moderate COVID-19 patients improve
By Reuters Staff (Reuters) - Gilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in a late-stage study. Remdesivir is being closely
Gilead trades that made millions on COVID-19 drug news raise eyebrows
By Saqib Iqbal Ahmed and Katanga Johnson NEW YORK/WASHINGTON (Reuters) - Well-timed trades in Gilead Sciences Inc's options ahead of good news on the biopharmaceutical company's COVID-19 drug
FDA approves emergency use of Abiomed heart pump for COVID-19 patients
By Reuters Staff (Reuters) - Abiomed Inc said on Monday the U.S. Food and Drug Administration has granted emergency use authorization for its temporary invasive heart pump to help patients suffering
Mavacamten promising in nonobstructive hypertrophic cardiomyopathy
By David Douglas NEW YORK (Reuters Health) - Mavacamten, an investigational myosin inhibitor, seems safe and well tolerated in most patients with nonobstructive hypertrophic cardiomyopathy (HCM), a
Developmental regression in Down syndrome should prompt careful evaluation
By Will Boggs MD NEW YORK (Reuters Health) - Down syndrome disintegrative disorder (DSDD), a loss of previously acquired functioning in young people with Down syndrome, is not part of the natural
TNF overcomes medulloblastoma immune evasion
By Will boggs MD NEW YORK (Reuters Health) - Tumor-necrosis factor (TNF) restores expression of surface class I major histocompatibility complex (MHC-I) in p53-mutant medulloblastoma, thereby
Camrelizumab improves survival in esophageal squamous-cell carcinoma
By Will Boggs MD NEW YORK (Reuters Health) - The anti-PD-1 antibody camrelizumab boosts survival in patients with advanced or metastatic esophageal squamous-cell carcinoma as second-line therapy,
CORRECTED-Enzalutamide improves survival in castration-resistant prostate cancer
(Fixes spelling of Astellas in para 8, in story originally posted May 29.) By Gene Emery (Reuters Health) - Adding enzalutamide to androgen-deprivation therapy extends overall survival by 27% in men
U.S. House Democrats launch inquiry into Medicare stimulus payouts
By Sarah N. Lynch and Marisa Taylor WASHINGTON (Reuters) - Two U.S. House of Representatives Democrats on Friday launched an inquiry into whether the Health and Human Services Department misdirected
Trump says terminating U.S. relationship with World Health Organization over virus
By Steve Holland and Michelle Nichols WASHINGTON/UNITED NATIONS (Reuters) - U.S. President Donald Trump on Friday said he is terminating the U.S. relationship with the World Health Organization over
Missouri's only abortion clinic wins licensing battle against state health dept
By Gabriella Borter (Reuters) - Missouri's only abortion clinic on Friday won its case against the state's health department to remain open, as an independent arbiter found the agency was unjustified
COVID SCIENCE-Coronavirus infection rate may shift toward younger ages; death risk higher in cancer patients
By Nancy Lapid (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness
Hard to predict which adults will benefit from cochlear implants
By Lisa Rapaport (Reuters Health) - Many adults with hearing loss that isn't improved with hearing aids can benefit from cochlear implants, but a new meta-analysis suggests patient characteristics are
Gun violence rose in some U.S. cities during Covid-19 shutdowns
By Lisa Rappaport (Reuters Health) - Gun violence was on the rise in several major American cities amid stay-at-home orders issued in response to the global Covid-19 pandemic, a new study suggests.
